Subsequent Events (Details) - Subsequent Event [Member] - USD ($) |
1 Months Ended | |||
|---|---|---|---|---|
May 19, 2021 |
Apr. 30, 2021 |
Apr. 29, 2021 |
Apr. 23, 2021 |
|
| Early Bird Settlement Agreement [Member] | ||||
| Subsequent Events (Details) [Line Items] | ||||
| Description of agreement | the Company settled the amounts due pursuant to a certain finder agreement entered into with EarlyBird Capital, Inc. (“EarlyBird”) on October 17, 2017 (the “Finder Agreement”). The Company’s Board of Directors determined it was in the best interests to settle all claims which had been made or could be made with respect to the Finder Agreement and entered into a settlement agreement (the “Settlement Agreement”). Pursuant to the Settlement Agreement, the Company paid EarlyBird a cash payment of $275,000 and issued 225,000 shares of the Company’s restricted common stock to EarlyBird. | |||
| Larsen Consulting Agreement [Member] | ||||
| Subsequent Events (Details) [Line Items] | ||||
| Description of agreement | the Company entered into a consulting agreement with Glenn Larsen, the former Chief Executive Officer of 180 Therapeutics LP, to act in the capacity as negotiator for the licensing of four patents. In consideration for services provided, the Company agreed to compensate Mr. Larsen with $50,000 of its restricted common stock (valued based on the closing sales price of the Company’s common stock on the date the Board of Directors approved the agreement, which shares have not been issued to date) which vests upon the Company entering into a licensing transaction with the assistance of Mr. Larsen. | |||
| Consulting Agreement [Member] | ||||
| Subsequent Events (Details) [Line Items] | ||||
| Issued shares of common stock | 37,715 | |||
| PPP Loan [Member] | ||||
| Subsequent Events (Details) [Line Items] | ||||
| Forgiveness amount | $ 51,051 | |||